Narayana Hrudayalaya Ltd

- No immediate plan for preferential equity issue in the next year; if needed, it will be considered much later. (Page 30) - Debt raising is primarily for expansion purposes, with an expected interest rate around 8% for India borrowings and 6-6.25% for Cayman borrowings. (Page 30) - Planned capex funding includes around 60-65% debt financing, with the remainder from internal cash flows. (Pages 15-16) - The company currently has significant cash reserves and low net debt levels compared to EBITDA but intends to leverage its borrowing capacity to fund growth. (Pages 15-16) - No plans for equity fundraising currently; focus remains on prudent use of debt and cash for expansion, with flexibility retained for future needs. (Pages 15, 30)

- FY26 capex guidance is around INR 400-450 crores excluding replacement costs; INR 425 crores projected spend (Page 15). - Capex is split between regular maintenance/replacement (~INR 300 crores) and new greenfield/brownfield capacity (~INR 450 crores) with some variability based on construction progress (Page 12 & 15). - Capex amounts are based on committed projects; delays or opportunities may push spends to FY27/FY28 (Page 15). - Debt will fund about 60-65% of total capex, with remaining funded from internal resources (Page 16 & 13). - Large cash corpus (~INR 1,600 crores) can be used for new projects or repayment of high-interest loans (Page 16). - Overseas expansion focused on Caribbean-like countries; small prior investment in Bahamas; monitoring international opportunities (Page 12 & 23). - Prudent use of cash reserves to seize good opportunities while managing leverage (Page 22 & 23).

- The company aspires to sustain growth through throughput and efficiency improvements, aiming to maintain past growth momentum (around 10-15% annually), though no definitive forward guidance is given. - Expansion plans include new facilities in Kolkata, Raipur, Shimoga, and exploration of other markets with strong presence for organic growth. - Oncology and orthopedics are growing roughly at 20-25%; cardiac business expected to maintain 25-30% growth over three years. - India business projected to grow ~14-15% standalone, excluding international patient flows. - International patient revenue has bottomed out and expected to decline to zero, impacting margins positively due to higher domestic realization. - Chemotherapy retail centers planned to expand outside hospitals to meet demand in urban areas. - Long-term target includes opening around 40 hospitals in 10 years, though exact numbers may fluctuate.

- The company aspires to improve profitability every year but does not provide explicit forward guidance on earnings or profit growth. - Organic growth is expected without major capacity additions, aiming to sustain past growth rates in revenue and profitability. - Growth drivers include efficiency improvements, increased throughput, minimal invasive procedures, and new technologies like AI/ML. - Oncology and orthopedics are seeing temporary high growth (~20-25%), with cardiac expected to maintain 25-30% growth long term. - Losses in clinics and insurance businesses are expected to grow in the short term due to expansion but will stabilize over 3-4 years within a set investment horizon. - Margins have reached a good level; focus will be on revenue growth rather than margin expansion beyond current levels. - No specific EPS guidance but overall outlook is conservative, emphasizing steady improvement without aggressive forward estimates.

The provided transcript pages do not contain any information related to the current or expected order book or pending orders. The discussion primarily focuses on attrition rates, AI incorporation and its impact on efficiency, patient footfalls, hospital expansions, insurance business, bed capacity changes, and related operational matters. No data or references about the order book or pending orders are mentioned on these pages. If you have other pages or sections of the document that might discuss order book or pending orders, please provide those so I can assist you better.